Audited UK Commercial PartnerHPLC Purity ≥98.7%Est. 2019

Direct Sarms

London, United Kingdom·Domain: direct-sarms.com

British research biochemical provider stocking analytical-grade synthetic peptides, high-precision receptor ligands, and pre-clinical laboratory reference complexes.

Analytical Standards

≥98.7% HPLC

Reverse-phase HPLC assays with UV diode array spectral detection at 214nm/254nm
Carrier dissolution profiling for receptor-binding laboratory studies
Minimum analytical purity baseline of ≥98.5% with lot-verified Certificates of Analysis

Packaging & Cold-Chain

Type I Glass

UV-blocking amber borosilicate containers with graduated laboratory transfer pipettes and induction-sealed tamper liners.

Tamper-evident crimp seals & desiccant preservation verified.

UK Express Dispatch

Tracked 24

United Kingdom Hub
European Union
Worldwide

Cold-pack insulated packaging for temperature-sensitive reagents.

Official Research Categories at Direct Sarms

Audited Catalog Inventory

Reagents Verified with Direct Sarms (7)

≥98.7% Third-Party Assay Guaranteed

Mixed Pre-ClinicalCAS 137525-51-0

BPC-157

Body Protection Compound-157 Pentadecapeptide

C62H98N16O221419.55 g/molTissue Repair & Angiogenesis

BPC-157 is a stable 15-amino acid synthetic pentadecapeptide fragment originally derived from human gastric juice protein BPC. Evaluated in UK academic and biotechnology laboratories as an analytical benchmark for focal adhesion kinase (FAK) activation and endothelial tube formation assays.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.2% (HPLC))Direct Peptides (≥99.1% (HPLC))Direct Sarms (≥98.8% (HPLC))Peptide Works (≥99.0% (HPLC))PharmaLab Global (≥99.4% (HPLC))

View Full Technical Monograph

Mixed Pre-ClinicalCAS 77591-33-4

TB-500

Thymosin Beta-4 Active Hexapeptide Domain (Ac-LKKTET-OH)

C212H350N56O78S4963.50 g/molTissue Repair & Angiogenesis

TB-500 represents the synthetic active fragment of Thymosin Beta-4, a major physiological actin-sequestering protein. Studied in British biomedical research for its ability to regulate G-actin polymerization, promote keratinocyte migration, and downregulate myofibroblast differentiation.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.0% (HPLC))Direct Peptides (≥98.9% (HPLC))Direct Sarms (≥98.5% (HPLC))Peptide Works (≥98.8% (HPLC))PharmaLab Global (≥99.2% (HPLC))

View Full Technical Monograph

Human Trial DataCAS 49557-75-7

GHK-Cu

Copper Tripeptide-1 Complex (Gly-His-Lys:Cu2+)

C14H24CuN6O4403.92 g/molDermal & Extracellular Matrix

GHK-Cu is a naturally occurring tripeptide-copper coordinate complex identified in human plasma. Investigated in UK cosmetic chemistry and cellular biology laboratories for its regulation of matrix metalloproteinases, decorin, and collagen I/III biosynthesis.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.3% (HPLC))Direct Peptides (≥99.1% (HPLC))Direct Sarms (≥98.7% (HPLC))Peptide Works (≥99.0% (HPLC))PharmaLab Global (≥99.5% (HPLC))

View Full Technical Monograph

Mixed Pre-ClinicalCAS 863288-34-0

CJC-1295

Modified Growth Hormone-Releasing Hormone (Mod GRF 1-29 / CJC-1295 No DAC)

C152H252N44O423367.97 g/molGrowth Hormone Secretagogues & GHRH

CJC-1295 (Mod GRF 1-29) is a synthetic 29-amino-acid analogue of human growth hormone-releasing factor featuring four D-amino acid substitutions to enhance metabolic stability against dipeptidyl peptidase-4 (DPP-4). Evaluated in UK endocrine research for pulsatile somatotroph signaling.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.2% (HPLC))Direct Peptides (≥99.0% (HPLC))Direct Sarms (≥98.6% (HPLC))Peptide Works (≥98.8% (HPLC))PharmaLab Global (≥99.4% (HPLC))

View Full Technical Monograph

Human Trial DataCAS 170851-70-4

Ipamorelin

Aib-His-D-2-Nal-D-Phe-Lys-NH2 Pentapeptide

C38H49N9O5711.86 g/molGrowth Hormone Secretagogues & GHRH

Ipamorelin is a synthetic pentapeptide and selective ghrelin receptor (GHSR-1a) agonist. Distinct from earlier GHRPs due to its selectivity: it stimulates somatotroph growth hormone release in vitro without triggering substantial elevation in cortisol, prolactin, or ACTH.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.3% (HPLC))Direct Peptides (≥99.1% (HPLC))Direct Sarms (≥98.8% (HPLC))Peptide Works (≥99.0% (HPLC))PharmaLab Global (≥99.5% (HPLC))

View Full Technical Monograph

Mixed Pre-ClinicalCAS 221231-10-3

AOD-9604

Human Growth Hormone C-Terminal Fragment (Tyr-hGH177-191)

C78H123N23O23S21815.12 g/molMetabolic & Incretin Signaling

AOD-9604 is a synthetic hexadecapeptide analog representing the lipolytic C-terminal domain of human growth hormone (hGH 177-191) with an added tyrosine residue. Investigated in UK metabolic and adipose tissue laboratories for beta-3 adrenergic receptor signaling without diabetogenic IGF-1 elevation.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.1% (HPLC))Direct Peptides (≥99.0% (HPLC))Direct Sarms (≥98.5% (HPLC))Peptide Works (≥98.7% (HPLC))PharmaLab Global (≥99.3% (HPLC))

View Full Technical Monograph

Human Trial DataCAS 2023788-19-2

Tirzepatide

Dual GIP and GLP-1 Receptor Co-Agonist 39-AA Synthetic Peptide

C225H348N48O684813.45 g/molMetabolic & Incretin Signaling

Tirzepatide is a synthetic 39-amino-acid unimolecular dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor co-agonist conjugated to a C20 fatty diacid moiety. Studied extensively in UK biochemical and pharmaceutical research for receptor affinity dynamics.

Verified UK Sourcing Partners:

PharmaGrade Store (≥99.3% (HPLC))Direct Peptides (≥99.2% (HPLC))Direct Sarms (≥98.8% (HPLC))Peptide Works (≥99.0% (HPLC))PharmaLab Global (≥99.5% (HPLC))

View Full Technical Monograph